Search

Is pharma R&D earning its investment?

They are some of the largest spenders on research. But now, as pharmaceutical companies look to external collaboration and in-licensed products to fuel innovation, the internal R&D operation is having to justify the return on investment for the first time
News

China’s seismic shift in IP

As China becomes a major generator of intellectual property, so it is becoming more committed to protecting IP and enforcing the law
News

Cut agriculture for the sake of science

The UK may have used its veto on treaty change, but it will support increased spending on R&D from 2014 – 2020, as proposed in Horizon 2020. Cutting agriculture subsidies could pay for this, Business Minister Vince Cable tells Science|Business
News

Open Innovation and Public Policy in Europe

This report combines new research and analysis on open innovation with focused interviews of major participants in the European innovation system. The recommendations comprise an informal ‘charter’ for EU open innovation policy. The study was conducted by Prof. Henry Chesbrough of ESADE Business School and the University of California, Berkeley and Prof. Wim Vanhaverbeke, of ESADE in Barcelona, Vlerick Management School and the University of Hasselt, in Belgium.

Report
Free